Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ryan

Showing results (1141-1150 of 1,164) with videos related to

Pageof 117
Sort By:
Alcoholism, Clinical and Experimental Research|February 14, 2012
A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patientsJoanne B Fertig, Megan L Ryan, Daniel E Falk, et al.
ERJ Open Research|October 30, 2020
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019Darcy E Wagner, Laertis Ikonomou, Sarah E Gilpin, et al.
Leukemia|December 22, 2022
Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trialClaire Schwab, Ruth E Cranston, Sarra L Ryan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 24, 2016
A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol DependenceMegan L Ryan, Daniel E Falk, Joanne B Fertig, et al.
Leukemia|May 12, 2016
The role of the RAS pathway in iAMP21-ALLS L Ryan, E Matheson, V Grossmann, et al.
Leukemia|January 19, 2023
Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemiaSarra L Ryan, John F Peden, Zoya Kingsbury, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 28, 2022
Stem cells, cell therapies, and bioengineering in lung biology and disease 2021Laertis Ikonomou, Mattias Magnusson, Ruben Dries, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2023
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trialL M Spring, S M Tolaney, G Fell, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 21, 2024
Stem cells, cell therapies, and bioengineering in lung biology and diseases 2023Robert E Hynds, Chelsea M Magin, Laertis Ikonomou, et al.
Cancer|February 11, 2025
A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastomaSteven G DuBois, Chitose Ogawa, Lucas Moreno, et al.
Pageof 117

Showing results (1141-1150 of 1,164) with videos related to

Sort By:
Pageof 117
Alcoholism, Clinical and Experimental Research|February 14, 2012
A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patientsJoanne B Fertig, Megan L Ryan, Daniel E Falk, et al.
ERJ Open Research|October 30, 2020
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019Darcy E Wagner, Laertis Ikonomou, Sarah E Gilpin, et al.
Leukemia|December 22, 2022
Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trialClaire Schwab, Ruth E Cranston, Sarra L Ryan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 24, 2016
A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol DependenceMegan L Ryan, Daniel E Falk, Joanne B Fertig, et al.
Leukemia|May 12, 2016
The role of the RAS pathway in iAMP21-ALLS L Ryan, E Matheson, V Grossmann, et al.
Leukemia|January 19, 2023
Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemiaSarra L Ryan, John F Peden, Zoya Kingsbury, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 28, 2022
Stem cells, cell therapies, and bioengineering in lung biology and disease 2021Laertis Ikonomou, Mattias Magnusson, Ruben Dries, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2023
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trialL M Spring, S M Tolaney, G Fell, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 21, 2024
Stem cells, cell therapies, and bioengineering in lung biology and diseases 2023Robert E Hynds, Chelsea M Magin, Laertis Ikonomou, et al.
Cancer|February 11, 2025
A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastomaSteven G DuBois, Chitose Ogawa, Lucas Moreno, et al.
Pageof 117